1.
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controll...
by Baigent, Colin, Prof
The Lancet (British edition), 2011, Vol.377 (9784), p.2181-2192
2.
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
by Levin, Adeera, Dr
The Lancet (British edition), 2017-10-21, Vol.390 (10105), p.1888-1917
3.
SHARP: a stab in the right direction in chronic kidney disease
by Stevens, Kathryn K
The Lancet (British edition), 2011, Vol.377 (9784), p.2153-2154
4.
Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study...
by Roth, David, Dr
The Lancet (British edition), 2015, Vol.386 (10003), p.1537-1545
5.
Living kidney donation: outcomes, ethics, and uncertainty
by Reese, Peter P, Dr
The Lancet (British edition), 2015, Vol.385 (9981), p.2003-2013
6.
Signing up for nephrology: the silence is broken in South Africa
by Fabian, June
The Lancet (British edition), 2015, Vol.385 (9983), p.2150-2151
7.
Chronic kidney disease: refining diagnosis and management
by Lancet, The
The Lancet (British edition), 2014, Vol.384 (9941), p.378-378
8.
Towards eradication of hepatitis C virus from dialysis units
by Jadoul, Michel
The Lancet (British edition), 2015, Vol.386 (10003), p.1514-1515
9.
Benefits of lowering cholesterol in chronic kidney disease
by Al-Rasadi, Khalid
The Lancet (British edition), 2011, Vol.378 (9800), p.1376-1377
10.
Benefits of lowering cholesterol in chronic kidney disease
by de Tena, Jaime García
The Lancet (British edition), 2011, Vol.378 (9800), p.1376-1376
11.
Benefits of lowering cholesterol in chronic kidney disease
by Mascitelli, Luca
The Lancet (British edition), 2011, Vol.378 (9800), p.1376-1376
12.
Benefits of lowering cholesterol in chronic kidney disease
by Lui, Philip
The Lancet (British edition), 2011, Vol.378 (9800), p.1375-1375
13.
The double challenge of resistant hypertension and chronic kidney disease
by Rossignol, Patrick, Prof
The Lancet (British edition), 2015, Vol.386 (10003), p.1588-1598
14.
Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis
by Jamal, Sophie A, Dr
The Lancet (British edition), 2013, Vol.382 (9900), p.1268-1277
15.
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
by Gansevoort, Ron T, Dr
The Lancet (British edition), 2013-07-27, Vol.382 (9889), p.339-352
16.
Acute-on-chronic liver failure
by Bernal, William, Dr
The Lancet (British edition), 2015, Vol.386 (10003), p.1576-1587
17.
Acral retiform purpura
by Li, Janet Y
The Lancet (British edition), 2017-11-25, Vol.390 (10110), p.2382-2382
18.
Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy
by Swanson, S John
The Lancet (British edition), 2002-11-23, Vol.360 (9346), p.1662-1664
19.
Mycophenolate mofetil monotherapy in liver transplantation
by Stewart, SF
The Lancet (British edition), 2001-02-24, Vol.357 (9256), p.609-610
20.
Renal function during antihypertensive treatment
by Madhavan, S
The Lancet (British edition), 1995, Vol.345 (8952), p.749-751
